Corbus Pharmaceuticals Holding Stock Filter Stocks by Fundamentals
| CRBP Stock | USD 17.47 0.74 4.42% |
Corbus Pharmaceuticals Holding fundamentals help investors to digest information that contributes to Corbus Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Corbus Stock. The fundamental analysis module provides a way to measure Corbus Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Corbus Pharmaceuticals stock.
Corbus | Shares Owned by Institutions |
Corbus Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Corbus Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Corbus Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Corbus Pharmaceuticals Institutional Holders
Institutional Holdings refers to the ownership stake in Corbus Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Corbus Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Corbus Pharmaceuticals' value.| Shares | Geode Capital Management, Llc | 2024-09-30 | 249.8 K | Woodline Partners Lp | 2024-06-30 | 249.3 K | Millennium Management Llc | 2024-06-30 | 241.6 K | Assenagon Asset Management Sa | 2024-09-30 | 221.2 K | Hhg Plc | 2024-06-30 | 203.3 K | Altium Capital Management, Lp | 2024-09-30 | 195 K | Silverarc Capital Management, Llc | 2024-06-30 | 172.5 K | Vivo Capital, Llc | 2024-09-30 | 166.8 K | Ghost Tree Capital, Llc | 2024-09-30 | 160 K | Cormorant Asset Management, Llc | 2024-09-30 | 2.4 M | Octagon Capital Advisors Lp | 2024-09-30 | 1.1 M |
Corbus Fundamentals
| Return On Equity | -0.51 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | 57.02 M | ||||
| Shares Outstanding | 12.18 M | ||||
| Shares Owned By Insiders | 0.70 % | ||||
| Shares Owned By Institutions | 99.30 % | ||||
| Number Of Shares Shorted | 2.38 M | ||||
| Price To Earning | (8.87) X | ||||
| Price To Book | 1.41 X | ||||
| Price To Sales | 163.32 X | ||||
| Gross Profit | (16.14 M) | ||||
| EBITDA | (44.44 M) | ||||
| Net Income | (44.6 M) | ||||
| Cash And Equivalents | 66.23 M | ||||
| Cash Per Share | 0.53 X | ||||
| Total Debt | 20.88 M | ||||
| Debt To Equity | 0.61 % | ||||
| Current Ratio | 3.86 X | ||||
| Book Value Per Share | 12.36 X | ||||
| Cash Flow From Operations | (36.1 M) | ||||
| Short Ratio | 5.39 X | ||||
| Earnings Per Share | (4.71) X | ||||
| Target Price | 59.5 | ||||
| Number Of Employees | 19 | ||||
| Beta | 2.57 | ||||
| Market Capitalization | 212.78 M | ||||
| Total Asset | 28.27 M | ||||
| Retained Earnings | (436.68 M) | ||||
| Working Capital | (8.35 M) | ||||
| Current Asset | 12.71 M | ||||
| Current Liabilities | 3.63 M | ||||
| Net Asset | 28.27 M |
About Corbus Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Corbus Pharmaceuticals Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Corbus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Corbus Pharmaceuticals Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Corbus Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Corbus Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corbus Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Corbus Stock
Moving against Corbus Stock
The ability to find closely correlated positions to Corbus Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Corbus Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Corbus Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Corbus Pharmaceuticals Holding to buy it.
The correlation of Corbus Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Corbus Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Corbus Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Corbus Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Corbus Stock Analysis
When running Corbus Pharmaceuticals' price analysis, check to measure Corbus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corbus Pharmaceuticals is operating at the current time. Most of Corbus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Corbus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corbus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Corbus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.